预约演示
Biotech in Israel: Holding on to business as usual amid uncertain times
2023-10-13
In the middle of our Zoom interview, Mati Gill, Tel Aviv-based CEO of venture studio AION Labs, excused himself calmly to find shelter when a siren started to run amok in the background. After five minutes, he returned and said: “I have to show an example for the kids — so I can’t skip out on running to the shelter.”
After militant group Hamas made attacks with thousands of rockets on Saturday, Israel has since declared a state of war. The events prompted words of support from pharma industry figureheads such as Pfizer CEO Albert Bourla, with Israel-based companies such as Teva reassuring observers that it
doesn’t anticipate an impact
on its business and operations.
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
适应症
-靶点
-药物
-Eureka LS:
全新生物医药AI Agent 覆盖科研全链路，让突破性发现快人一步
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。